These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Antiphospholipid antibodies in a heterogeneous group of patients: experience from a central laboratory. Mader R; Ziporen L; Mader R; Neumann L; Buskila D Clin Rheumatol; 2002 Sep; 21(5):386-90. PubMed ID: 12223987 [TBL] [Abstract][Full Text] [Related]
5. Laboratory detection of antiphospholipid antibodies. Kandiah DA; Krilis SA Lupus; 1996 Apr; 5(2):160-2. PubMed ID: 8743133 [TBL] [Abstract][Full Text] [Related]
6. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests. Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167 [TBL] [Abstract][Full Text] [Related]
7. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome. Arnout J Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685 [TBL] [Abstract][Full Text] [Related]
8. Lupus anticoagulant and anticardiolipin antibodies in systemic lupus erythematosus. Saxena R; Saraya AK; Dhot PS; Singh Y; Malaviya AN Natl Med J India; 1994; 7(4):163-5. PubMed ID: 7950946 [TBL] [Abstract][Full Text] [Related]
9. [Phospholipid antibodies (lupus anticoagulant and cardiolipin antibodies). Detection and clinical significance]. Wisløff F; Sletnes KE; Schjetlein R Tidsskr Nor Laegeforen; 1993 Aug; 113(18):2269-72. PubMed ID: 8362396 [TBL] [Abstract][Full Text] [Related]
14. Plasma reactivity to hexagonal II phase phosphatidylethanolamine is more frequently associated with lupus anticoagulant than with antiphosphatidylethanolamine antibodies. Berard M; Boffa MC; Karmochkine M; Aillaud MF; Juhan-Vague I; Francès C; Cacoub P; Piette JC; Harlé JR J Lab Clin Med; 1993 Nov; 122(5):601-5. PubMed ID: 8228579 [TBL] [Abstract][Full Text] [Related]
15. Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus. Alessandri C; Bombardieri M; Di Prospero L; Conigliaro P; Conti F; Labbadia G; Misasi R; Sorice M; Valesini G Clin Exp Immunol; 2005 Apr; 140(1):173-80. PubMed ID: 15762889 [TBL] [Abstract][Full Text] [Related]
16. [Antiphospholipid antibodies: clinical significance and biological diagnosis]. Arnoux D; Boutière B; Sanmarco M Ann Biol Clin (Paris); 2000; 58(5):557-74. PubMed ID: 11022099 [TBL] [Abstract][Full Text] [Related]
18. [Laboratory diagnosis of lupus anticoagulant]. Swadźba J; Musiał J; Jankowski M; Bednarczyk M; Dyczek A; Szczeklik A Pol Merkur Lekarski; 1996 Nov; 1(5):359-62. PubMed ID: 9273219 [TBL] [Abstract][Full Text] [Related]
19. Do not forget lupus anticoagulant in the era of antiphospholipid antibodies. Stratta P; Canavese C; Ferrero S; Grill A; Borchellini A; Schinco P Nephron; 1997; 76(2):233-4. PubMed ID: 9200421 [No Abstract] [Full Text] [Related]
20. Antiphospholipid antibodies: a disease marker in 25 patients with antinuclear antibody negative systemic lupus erythematosus (SLE). Comparison with a group of 91 patients with antinuclear antibody positive SLE. Meyer O; Piette JC; Bourgeois P; Fallas P; Bletry O; Jungers P; Kahn MF; Godeau P; Ryckewaert A J Rheumatol; 1987 Jun; 14(3):502-6. PubMed ID: 3114485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]